Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Robbins

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
The American Journal of Tropical Medicine and Hygiene|April 6, 2001
The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of VietnamF Y Lin, A H Vo, V B Phan, et al.
Journal of Clinical Microbiology|June 1, 1988
Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodiesF Y Lin, J M Becke, C Groves, et al.
Lancet (London, England)|August 3, 1974
Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type BM S Schiffer, J MacLowry, R Schneerson, et al.
The Journal of Infectious Diseases|December 1, 1983
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groupsJ B Robbins, R Austrian, C J Lee, et al.
The Journal of Infectious Diseases|May 6, 1999
Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in childrenS Ashkenazi, J H Passwell, E Harlev, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Infection and Immunity|February 17, 2001
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in IsraelJ H Passwell, E Harlev, S Ashkenazi, et al.
The New England Journal of Medicine|April 26, 2001
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old childrenF Y Lin, V A Ho, H B Khiem, et al.
The Journal of Biological Chemistry|February 28, 1998
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and InabaJ Wang, S Villeneuve, J Zhang, et al.
Infection and Immunity|October 26, 1999
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in VietnamZ Kossaczka, F Y Lin, V A Ho, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
The American Journal of Tropical Medicine and Hygiene|April 6, 2001
The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of VietnamF Y Lin, A H Vo, V B Phan, et al.
Journal of Clinical Microbiology|June 1, 1988
Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodiesF Y Lin, J M Becke, C Groves, et al.
Lancet (London, England)|August 3, 1974
Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type BM S Schiffer, J MacLowry, R Schneerson, et al.
The Journal of Infectious Diseases|December 1, 1983
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groupsJ B Robbins, R Austrian, C J Lee, et al.
The Journal of Infectious Diseases|May 6, 1999
Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in childrenS Ashkenazi, J H Passwell, E Harlev, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Infection and Immunity|February 17, 2001
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in IsraelJ H Passwell, E Harlev, S Ashkenazi, et al.
The New England Journal of Medicine|April 26, 2001
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old childrenF Y Lin, V A Ho, H B Khiem, et al.
The Journal of Biological Chemistry|February 28, 1998
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and InabaJ Wang, S Villeneuve, J Zhang, et al.
Infection and Immunity|October 26, 1999
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in VietnamZ Kossaczka, F Y Lin, V A Ho, et al.
Pageof 23